Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2021-06-14 Share Issue/Capital Cha…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Share capital increase registered
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces that a share capital increase, previously announced on June 7, 2021, has now been registered with the Norwegian Register of Business Enterprises. It details the number of new shares issued (98,251) and the resulting total share capital and number of shares. This content directly relates to a change in the company's capital structure via the issuance of new shares, which aligns perfectly with the definition of 'Share Issue/Capital Change' (Code: SHA). The document length is short (1517 chars), but it is a direct announcement of a capital change, not merely an announcement *about* a report, making SHA more specific than RPA or RNS.
2021-06-14 English
Photocure ASA: Exercise of employee share options - Correction
Director's Dealing Classification · 99% confidence The document text consists of structured tables detailing transactions involving shares by individuals identified as 'Person discharging managerial responsibilities' (CEO and CFO) of PHOTOCURE ASA. Specifically, it reports the 'Purchase of shares' under an employee share option program. This type of filing, which reports personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing. This matches the definition for Director's Dealing (Code: DIRS).
2021-06-09 English
Photocure ASA: Exercise of employee share options - Correction
Transaction in Own Shares Classification · 98% confidence The document is a correction notice regarding the exercise of employee share options by primary insiders (CEO, CFO, VPs) and the subsequent purchase of shares using the net proceeds. It explicitly mentions the transaction price and the number of shares purchased by specific executives. This type of filing, detailing personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions 'Primary insider notifications pursuant to the market abuse regulation article 19 are attached', the core content is the insider transaction disclosure itself, making DIRS the most appropriate classification over a general Regulatory Filing (RNS) or a Transaction in Own Shares (POS), as POS usually refers to the company buying back its own stock, whereas this focuses on insider trades.
2021-06-09 English
Photocure ASA: Exercise of employee share options - Correction
Transaction in Own Shares Classification · 99% confidence The document is a correction notice regarding the exercise of employee share options by primary insiders (CEO, CFO, VPs) and the subsequent purchase of shares by these insiders using the net proceeds. It explicitly mentions that primary insider notifications pursuant to the market abuse regulation article 19 are attached. This type of transaction report, detailing personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). The document is short and focuses on insider transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core information itself.
2021-06-09 English
Photocure ASA: Acquisition of own shares under the share buy-back program for incentive scheme
Transaction in Own Shares Classification · 99% confidence The document title is "PHOTOCURE ASA – REPORT ON REPURCHASE TRANSACTION". The content details the price, volume, and date of a transaction involving the company's own shares (26,268 shares repurchased at NOK 142.1646). This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance), which maps to the filing code POS.
2021-06-08 English
Photocure ASA: Acquisition of own shares under the share buy-back program for incentive scheme
Transaction in Own Shares Classification · 99% confidence The document explicitly discusses the completion of a 'share buyback program' where the Company 'acquired a total of 26,268 own shares' and subsequently sold them to employees under an incentive scheme. This directly relates to the company transacting in its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a short announcement (1837 chars) detailing the transaction results, not a comprehensive report, confirming it is a specific transaction announcement rather than a general filing.
2021-06-08 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.